Safety, efficacy, and immunogenicity of a replication-defective human cytomegalovirus vaccine, V160, in cytomegalovirus-seronegative women: a double-blind, randomised, placebo-controlled, phase 2b trial
Titel:
Safety, efficacy, and immunogenicity of a replication-defective human cytomegalovirus vaccine, V160, in cytomegalovirus-seronegative women: a double-blind, randomised, placebo-controlled, phase 2b trial
Auteur:
Das, Rituparna Blázquez-Gamero, Daniel Bernstein, David I Gantt, Soren Bautista, Oliver Beck, Karen Conlon, Anthony Rosenbloom, Daniel I S Wang, Dai Ritter, Michael Arnold, Beth Annunziato, Paula Russell, Kevin L